Eli Lilly Reduces Cash Prices of Zepbound Weight Loss Drug Vials on Direct-to-Consumer Platform
Eli Lilly Reduces Cash Prices of Zepbound Weight Loss Drug Vials on Direct-to-Consumer Platform In a significant development within the pharmaceutical and weight management sectors, Eli Lilly has announced a reduction in the cash prices of its weight loss drug, Zepbound, when purchased directly through…
- Los Gatos ‘Party Mom’ Who Supplied Teens With Alcohol and Pressured Them Faces Lengthy Jail Sentence

- Anti-AIPAC Group Faces Setback as Rep. Valerie Foushee Wins Primary Battle

- Texas Judge Declines to Close Camp Mystic but Bars Construction on Flood-Damaged Campus

- Netflix, After Walking Away From Warner Bros. Deal, Will Move Forward With $2.8 Billion Cash Reserve, CFO Says

- Democratic Rivals in Close Senate Primary Amid Texas Polling Confusion
